Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Gene Therapy for Sickle Cell Disease Is Associated with a Decreased Transplant Length of Stay and Similar Rates of Short-Term Complications Compared to Allogeneic Matched Sibling Stem Cell Transplant: A Single Center Experience

Lev Gorfinkel, Erica B. Esrick, Alexander Lake, Miki Nishitani, Malika Kapadia, Amy Federico, Colleen Dansereau, David A. Williams, Leslie E. Lehmann

Blood (2024) 144 (Supplement 1): 3574.

https://doi.org/10.1182/blood-2024-198677

Published: 2024

Journal Articles

Impact of CD3 Expression on Outcome of Pediatric Anaplastic Large Cell Lymphoma

Ahmed Obeid, Hanafy Hafez, Samah Fathy Semary, Eman Nageb, Sonya Fahmy Soliman, Iman Zaky, Mohammed Kamal, Leslie E. Lehmann, Alaa Elhaddad

Blood (2024) 144 (Supplement 1): 6406.

https://doi.org/10.1182/blood-2024-205707

Published: 2024

Journal Articles

Risk of Depression and Anxiety Post Allogeneic Hematopoietic Stem Cell Transplant in Pediatric Patients with Cancer in a Low-Middle-Income Country (LMIC)

Sally Boshra, Hanafy Hafez, Mahmoud Hammad, Leslie E. Lehmann, Taghreed Mohamed, Nayera Hamdy, Ahmed Mosa, Alaa Elhaddad

Blood (2024) 144 (Supplement 1): 7390.

https://doi.org/10.1182/blood-2024-207112

Published: 2024

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia - Retrospective Dual-Center Study

Blood (2023) 142 (Supplement 1): 4979.

https://doi.org/10.1182/blood-2023-179962

Published: 2023

Journal Articles

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Molly Tokaz, Helen Baldomero, Andrew J Cowan, Wael Saber, Hildegard T. Greinix, Mickey Koh, Nicolaus Kröger, Mohamad Mohty, Sebastian Galeano, Shinichiro Okamoto, Naeem A. Chaudhri, Amado J Karduss, Fabio Ciceri, Vergilio Rensi Colturato, Selim Corbacioglu, Alaa M. Elhaddad, Lisa Force, Cristobal Augusto Frutos Ortiz, Andres Gomez-De Leon, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius YL Ho, Xiao-Jun Huang, Benjamin Jacobs, Heeje Kim, Minako Iida, Leslie E. Lehmann, Régis Peffault de Latour, Mary-Elizabeth M. Percival, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor-Sheng Ko, Anderson Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A Snowden, Daniel J. Weisdorf, Jakob R. Passweg, Marcelo C Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser, Martina Perdomo

Blood (2022) 140 (Supplement 1): 8146–8149.

https://doi.org/10.1182/blood-2022-158338

Published: 2022

Journal Articles

Impact of Public Reporting of Center-Specific Analysis Scores on Hematopoietic Cell Transplant Center Volumes

Akshay Sharma, Brent Logan, Noel Estrada-Merly, Leslie E. Lehmann, Hemalatha G. Rangarajan, Jaime M. Preussler, Jesse D. Troy, Luke P. Akard, Neel S. Bhatt, Tony H. Truong, William A. Wood, Jr., Douglas Rizzo, Wael Saber

Blood (2022) 140 (Supplement 1): 10845–10846.

https://doi.org/10.1182/blood-2022-163451

Published: 2022

Journal Articles

Does Race/Ethnicity Impact Umbilical Cord Blood Transplant Outcomes in a Contemporary Era?

Karen K. Ballen, Tao Wang, Naya He, Shahrukh Hashmi, Leslie E. Lehmann, William A. Wood, Jr., Hemalatha G. Rangarajan, Wael Saber

Blood (2022) 140 (Supplement 1): 685–686.

https://doi.org/10.1182/blood-2022-159152

Published: 2022

Journal Articles

International Collaborative Study to Compare the Prognosis for Acute Leukemia Patients Transplanted with Intensified Myeloablative Regimens

Blood (2022) 140 (Supplement 1): 4711–4713.

https://doi.org/10.1182/blood-2022-160305

Published: 2022

Journal Articles

Pediatrics Non-Hodgkin's Lymphoma Survivors: Should We Worry about Quality of Life and Late Therapy Effects?

Azza Ali Fahmy Ayad, Reham Abdelaziz Khedr, Asmaa Mohammed Hamoda, Tamer Diab, Nahla Elnabarawy, Elhamy Rifky, Leslie E. Lehmann, Alaa M. Elhaddad

Blood (2022) 140 (Supplement 1): 3837–3838.

https://doi.org/10.1182/blood-2022-168009

Published: 2022

Journal Articles

Changes in the Gut Microbial Diversity and Its Correlation with the Clinical Outcome in Children with Acute Myeloid Leukemia (AML) Receiving Induction Chemotherapy

Mai Adel, Reham Abdelaziz Khedr, Ahmed Elsayed, Lobna Shalaby, Abdelrahman Omar, Aya A. Diab, Mervat Elanany, Leslie E. Lehmann, Alaa Elhaddad

Blood (2022) 140 (Supplement 1): 11769–11770.

https://doi.org/10.1182/blood-2022-158654

Published: 2022

Journal Articles

Induction of Fetal Hemoglobin and Reduction of Clinical Manifestations in Patients with Severe Sickle Cell Disease Treated with Shmir-Based Lentiviral Gene Therapy for Post-Transcriptional Gene Editing of BCL11A: Updated Results from Pilot and Feasibility Trial

Blood (2022) 140 (Supplement 1): 10665–10667.

https://doi.org/10.1182/blood-2022-169089

Published: 2022

Journal Articles

Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥ 1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis

Brandon J. Blue, Ruta Brazauskas, Karen Chen, Shahrukh Hashmi, Leslie E. Lehmann, William A. Wood, Navneet S. Majhail, Wael Saber

Blood (2021) 138 (Supplement 1): 3929.

https://doi.org/10.1182/blood-2021-153357

Published: 2021

Journal Articles

Low Rates of Venoocclusive Disease and Non-Relapse Mortality in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Following Inotuzumab Ozogamicin Reinduction for Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia

Jonathan D. Paolino, Jiemin Yang, Andrew E. Place, Christine N. Duncan, Steven P. Margossian, Leslie E. Lehmann, John T. Horan, Malika Kapadia, Jennifer S. Whangbo, Francesca Alvarez Calderon, Melissa A. Burns, Leslie S. Kean, Lewis B. Silverman, Donna S. Neuberg, Susanne H.C. Baumeister

Blood (2021) 138 (Supplement 1): 2853.

https://doi.org/10.1182/blood-2021-152857

Published: 2021

Journal Articles

Trends in Use and Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Racial/Ethnic Minorities

Nandita Khera, Theresa E. Hahn, Ruta Brazauskas, Benjamin Jacobs, Leslie E. Lehmann, Hashmi Shahrukh, William A. Wood, Sikander Ailawadhi, Wael Saber

Blood (2021) 138 (Supplement 1): 427.

https://doi.org/10.1182/blood-2021-146967

Published: 2021

Journal Articles

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Erica B. Esrick, MD, Maureen Achebe, MD MPH, Myriam Armant, PhD, Pablo Bartolucci, MD PhD, Marioara Felicia Ciuculescu, MD, Heather Daley, Colleen Dansereau, MSN, RN, CPN, Giuseppe Di Caprio, PhD, Bronner Goncalves, MD PhD, Nicolas Hebert, Matthew M Heeney, MD, John M. Higgins, MD PhD, Leslie E. Lehmann, MD, John P Manis, MD, Olivier Negre, PhD, Sarah Nikiforow, MD PhD, Ethan Schonbrun, PhD, David K. Wood, PhD, David A. Williams, MD

Blood (2019) 134 (Supplement_2): LBA-5.

https://doi.org/10.1182/blood-2019-132745

Published: 2019

Journal Articles

Ten Years of Treating Chronic Myeloid Leukemia in Rural Rwanda: Feasible Approaches for Low-Resource Settings

Jennifer Morgan, MD, Jean Bosco Bigirimana, Cam Nguyen, MSPH, Rebecca Deboer, MD, Cyprien Shyirambere, MD, Alan Paciorek, Leslie E. Lehmann, MD, Lawrence N. Shulman, MD

Blood (2019) 134 (Supplement_1): 4788.

https://doi.org/10.1182/blood-2019-126152

Published: 2019

Journal Articles

Report on the Treatment of Hodgkin Lymphoma with ABVD Chemotherapy at Two Rural District Hospitals in Rwanda

Cyprien Shyirambere, MD, Rebecca Deboer, MD, Yvan Butera, MD, Caitlin Driscoll, resident, Jean Bosco Bigirimana, Francois Regis Uwizeye, Temidayo Fadelu, MD, Paul H Park, MD, Alan Paciorek, Leslie E. Lehmann, MD, Lawrence N. Shulman, MD

Blood (2019) 134 (Supplement_1): 4053.

https://doi.org/10.1182/blood-2019-130780

Published: 2019

Journal Articles

Flipping the Switch: Initial Results of Genetic Targeting of the Fetal to Adult Globin Switch in Sickle Cell Patients

Blood (2018) 132 (Supplement 1): 1023.

https://doi.org/10.1182/blood-2018-99-116733

Published: 2018

Journal Articles

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Kira O Bona, MDMPH, Ruta Brazauskas, PhD, Naya He, Leslie E. Lehmann, MD, Joanne Wolfe, MD MPH, Jignesh Dalal, MD, Shahrukh K. Hashmi, MDMPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Christine Duncan, MD MSc, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 714.

https://doi.org/10.1182/blood-2018-99-118544

Published: 2018

Journal Articles

Transplant Associated Thrombotic Microangiopathy (TA-TMA): Lessons Learned from a Large Pediatric Center

Michelle Schoettler, MD, Leslie E. Lehmann, MD, Pei-Chi Kao, MS, Maia Lee, Clement Ma, PhD, Christine Duncan, MD MSc

Blood (2018) 132 (Supplement 1): 2090.

https://doi.org/10.1182/blood-2018-99-110185

Published: 2018

NARROW

Gene Therapy for Sickle Cell Disease Is Associated with a Decreased Transplant Length of Stay and Similar Rates of Short-Term Complications Compared to Allogeneic Matched Sibling Stem Cell Transplant: A Single Center Experience

Impact of CD3 Expression on Outcome of Pediatric Anaplastic Large Cell Lymphoma

Risk of Depression and Anxiety Post Allogeneic Hematopoietic Stem Cell Transplant in Pediatric Patients with Cancer in a Low-Middle-Income Country (LMIC)

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia - Retrospective Dual-Center Study

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Impact of Public Reporting of Center-Specific Analysis Scores on Hematopoietic Cell Transplant Center Volumes

Does Race/Ethnicity Impact Umbilical Cord Blood Transplant Outcomes in a Contemporary Era?

International Collaborative Study to Compare the Prognosis for Acute Leukemia Patients Transplanted with Intensified Myeloablative Regimens

Pediatrics Non-Hodgkin's Lymphoma Survivors: Should We Worry about Quality of Life and Late Therapy Effects?

Changes in the Gut Microbial Diversity and Its Correlation with the Clinical Outcome in Children with Acute Myeloid Leukemia (AML) Receiving Induction Chemotherapy

Induction of Fetal Hemoglobin and Reduction of Clinical Manifestations in Patients with Severe Sickle Cell Disease Treated with Shmir-Based Lentiviral Gene Therapy for Post-Transcriptional Gene Editing of BCL11A: Updated Results from Pilot and Feasibility Trial

Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥ 1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis

Low Rates of Venoocclusive Disease and Non-Relapse Mortality in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Following Inotuzumab Ozogamicin Reinduction for Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia

Trends in Use and Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Racial/Ethnic Minorities

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Ten Years of Treating Chronic Myeloid Leukemia in Rural Rwanda: Feasible Approaches for Low-Resource Settings

Report on the Treatment of Hodgkin Lymphoma with ABVD Chemotherapy at Two Rural District Hospitals in Rwanda

Flipping the Switch: Initial Results of Genetic Targeting of the Fetal to Adult Globin Switch in Sickle Cell Patients

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Transplant Associated Thrombotic Microangiopathy (TA-TMA): Lessons Learned from a Large Pediatric Center

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only